Dr Lal Pathlabs Ltd
₹1838.20
-5.50 (0.30%)
Wed, 28 Oct 2026, 07:44 pm
Health Services
Medical/Nursing Services
24.5KDr Lal Pathlabs Share Price Live Chart
1 Day
-5.50 (0.30%)
No Result Found
Summary
Market Cap (in Cr)
31929.88
Net Profit (in Cr)
509.75
P/B
8.78
Sector P/E
59.23
P/E
43.61
EV/EBITDA
24.96
Debt/Equity (Industry)
0.21
Interest Cover (Industry)
13.13
ROCE (Industry)
19.40
RONW (Industry)
16.34
ROE
21.78
ROCE
27.45
Debt/Equity
0.08
EPS (TTM)
33.51
Dividend Yield
1.08
Book Value
149.45
Interest Cover
30.35
Analysis
all
- Dividends paid are well covered by earnings (2.3x coverage).
- Dividends after 3 years are expected to be well covered by earnings (3.9x coverage).
- Dr. Lal PathLabs's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Dr. Lal PathLabs's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Dr. Lal PathLabs is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
- Dividend payments have increased, but Dr. Lal PathLabs only paid a dividend in the past 4 years.
- Whilst dividend payments have been stable, Dr. Lal PathLabs has been paying a dividend for less than 10 years.
- Dr. Lal PathLabs's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dr. Lal PathLabs's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Dr. Lal PathLabs is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 52.93 | 53.19 | 53.21 | 53.22 | 53.22 |
| FII | 18.73 | 17.36 | 17.18 | 20.29 | 21.86 |
| DII | 21.58 | 21.59 | 21.38 | 19.21 | 18.49 |
| Public | 6.76 | 7.85 | 8.22 | 7.28 | 6.44 |
| Government | 0 | 0.01 | 0.01 | 0.01 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2326.23 | 2143.33 | 2065.17 | 1960.43 | 1882.27 | 1777.53 | 1594.63 |
| Fibonacci | 2143.33 | 2073.47 | 2030.30 | 1960.43 | 1890.57 | 1847.40 | 1777.53 |
| Camarilla | 2037.30 | 2020.53 | 2003.77 | 1960.43 | 1970.23 | 1953.47 | 1936.70 |
Pivots Level: Classic
R3
+365.80
2326.23
R2
+182.90
2143.33
R1
+104.73
2065.17
S1
-78.17
1882.27
S2
-182.90
1777.53
S3
-365.80
1594.63
Moving Average
Period
Value
10-EMA
1885.23
20-EMA
1897.07
30-EMA
1901.10
50-EMA
1888.97
100-EMA
1820.53
200-EMA
1713.47
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 24 Jul 2026 | dividend | ₹5.00 Dividend /Share | 30 Jul 2026 |
| 30 Apr 2026 | dividend | ₹4.00 Dividend /Share | 26 Jun 2026 |
| 30 Apr 2026 | board-meetings | Accounts, Quarterly Results | |
| 30 Apr 2026 | agm | ||
| 30 Jan 2026 | board-meetings | Quarterly Results | |
| 30 Jan 2026 | dividend | ₹3.50 Dividend /Share | 05 Feb 2026 |
| 05 Jan 2026 | dividend | Interim Dividend - Rs. - 3.5 | 05 Feb 2026 |
| 12 Dec 2025 | bonus | 1:1 Bonus Issue of Equity Shares | 12 Dec 2025 |
| 19 Nov 2025 | bonus | Bonus issue 1:1 | 19 Dec 2025 |
| 31 Oct 2025 | dividend | ₹7.00 Dividend /Share | 07 Nov 2025 |
Peer Comparison
Dr Lal Pathlabs Ltd
Apollo Hospitals Enterprise Ltd
Aster DM Quality Care Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Dr Lal Pathlabs Ltd About
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Industry
Healthcare
Founded
1995
Headquarters
CEO
Arvind Lal
Employees
Contact
Website
http://www.lalpathlabs.com
cs@lalpathlabs.com
Phone
91-011-3024 4149
Location
E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085
Dr Lal Pathlabs Ltd Company History
| Year | History |
|---|---|
| 2017 |
|
| 2018 |
|
| 2021 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 33414 | 3160 | 20 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 33414 | 3160 | 20 Oct 2025 |
| MULTI-MANAGER ICVC | bulk | Sell | 434943 | 2997.11 | 06 Jan 2025 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 12949 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 69319 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 69319 | 2550.9 | 25 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 12949 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 69250 | 2377.5 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 69250 | 2377.5 | 17 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 12934 | 2377.5 | 17 Oct 2022 |
Frequently Asked Questions
1.What is the stock price of Dr Lal Pathlabs Ltd?
As of 29/10/2026 at 1:14 AM, Dr Lal Pathlabs Ltd shares are trading at ₹1838.20.
2.What is the market cap. of Dr Lal Pathlabs Ltd?
As of 29/10/2026, the market capitalization of Dr Lal Pathlabs Ltd is ₹30,977.34 crore.
3.When was Dr Lal Pathlabs Ltd founded?
Dr Lal Pathlabs Ltd was founded in 1995.
4.What are the P/E and P/B ratios of Dr Lal Pathlabs Ltd?
As of 29/10/2026, Dr Lal Pathlabs Ltd has a P/E ratio of 56.74 and a P/B ratio of 8.78.
5.How can I buy shares of Dr Lal Pathlabs Ltd?
You can buy shares of Dr Lal Pathlabs Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Dr Lal Pathlabs Ltd?
As of September,2026, promoters hold 52.93% in Dr Lal Pathlabs Ltd, while FIIs, DIIs and public shareholders hold 18.73%, 21.58% and 6.76%, respectively.
7.Does Dr Lal Pathlabs Ltd pay dividends?
Yes, Dr Lal Pathlabs Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹5.00 Dividend /Share per share.
8.What is the dividend yield of Dr Lal Pathlabs Ltd?
As of 29 October, 2026, the dividend yield of Dr Lal Pathlabs Ltd stands at 0.87%.
9.What are the latest financial results of Dr Lal Pathlabs Ltd?
For the financial year ended March 2025, Dr Lal Pathlabs Ltd reported revenue of ₹2,461.00 crore and a net profit of ₹487.00 crore.
10.What is the Stock symbol of Dr Lal Pathlabs Ltd?
LALPATHLAB is the stock symbol of Dr Lal Pathlabs Ltd.
11.Who is the CEO of Dr Lal Pathlabs Ltd?
The CEO of Dr Lal Pathlabs Ltd is Arvind Lal.
